Literature DB >> 3244612

Effect of taurolithocholate on in vivo sulfation and glucuronidation of acetaminophen in rats.

R E Galinsky1, B Chałasinska.   

Abstract

Taurolithocholate produces a prompt, complete, and reversible cessation of bile flow in rats. This is associated with impaired hepatic oxidative drug-metabolizing activity. The purpose of this study was to examine the effects of taurolithocholate-induced cholestasis on in vivo conjugation. The pharmacokinetics of acetaminophen and the two major processes specifically responsible for its elimination, namely, the formations of acetaminophen sulfate and acetaminophen glucuronide, were used to assess hepatic conjugating activity. A 30-mg/kg bolus of acetaminophen was administered intravenously to rats 2 hr (acute cholestasis) or 20 hr (postcholestasis) after intravenous pretreatment with sodium taurolithocholate, 5 mumol/100 g body weight. Acute cholestasis increased the total clearance of acetaminophen 20%, the partial clearance to acetaminophen sulfate 12%, and the partial clearance to acetaminophen glucuronide 85%. Postcholestasis, these parameters had significantly decreased compared to those during acute cholestasis and were comparable to control values. The results show that cholestasis does not impair acetaminophen conjugation in the rat.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244612     DOI: 10.1023/a:1015871713954

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  CHRONIC INTRAVENOUS CANNULAS FOR RATS.

Authors:  J R WEEKS; J D DAVIS
Journal:  J Appl Physiol       Date:  1964-05       Impact factor: 3.531

2.  Biochemical and morphological parameters of taurolithocholate-induced cholestasis.

Authors:  B G Priestly; M G Côté; G L Plaa
Journal:  Can J Physiol Pharmacol       Date:  1971-12       Impact factor: 2.273

3.  Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion.

Authors:  R E Galinsky; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

4.  Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates.

Authors:  R N Allan; J L Thistle; A F Hofmann; J A Carter; P Y Yu
Journal:  Gut       Date:  1976-06       Impact factor: 23.059

5.  Effect of subchronic cholestasis on microsomal mixed-function oxidases and the glutathione-conjugating enzyme system in rat liver.

Authors:  M Younes; V Pauli; G Korb; C P Siegers
Journal:  Pharmacol Res Commun       Date:  1985-09

6.  Effect of prevention of inorganic sulfate depletion on the pharmacokinetics of acetaminophen in rats.

Authors:  J H Lin; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

7.  Diurnal variation of rat liver enzymes catalyzing bile acid conjugation and sulfation.

Authors:  R B Kirkpatrick; S F Robinson; P G Killenberg
Journal:  Biochim Biophys Acta       Date:  1980-12-05

8.  Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones.

Authors:  J W Marks; S O Sue; B J Pearlman; G G Bonorris; P Varady; J M Lachin; L J Schoenfield
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  Acetaminophen decreases adenosine 3'-phosphate 5'-phosphosulfate and uridine diphosphoglucuronic acid in rat liver.

Authors:  J J Hjelle; G A Hazelton; C D Klaassen
Journal:  Drug Metab Dispos       Date:  1985 Jan-Feb       Impact factor: 3.922

10.  Taurolithocholate increases heme catabolism and alters the clearance of antipyrine in the rat.

Authors:  W R Berry; G Kirshenbaum; C Hoilien; M Le; J Reichen
Journal:  Gastroenterology       Date:  1985-02       Impact factor: 22.682

View more
  1 in total

Review 1.  Pharmacokinetics in the child.

Authors:  W R Crom
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.